Xylem
XYL
94.66
-0.58
-0.61%
Xylem
US · XYL
#827 by market cap
Listed 1970
94.66
-0.58
-0.61%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:33
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
1 4
■ Upgrades■ Downgrades
- 1 upgrade vs 4 downgrades among tracked analyst rating changes.
- Most recent: Argus Research moved from Buy to Hold on 2026-11-04.
Analyst consensus 14 analysts
Buy
Avg price target 118.08 +24.7%
Price target rangecurrent 94.66
Low90.00
Avg118.08
High150.00
Buy 50%
Hold 43%
Sell 7%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-04 | Argus Research | -- | Hold | -- |
| 2026-10-29 | UBS | -- | Hold | 99.00 |
| 2026-10-28 | TD Cowen | -- | Hold | 110.00 |
| 2026-10-28 | Mizuho Securities | -- | Hold | 99.00 |
| 2026-10-28 | Baird | -- | Buy | 123.00 |
| 2026-10-28 | Stifel | -- | Buy | 114.00 |
| 2026-10-28 | Citi | -- | Buy | 130.00 |
| 2026-10-28 | Barclays | -- | Hold | 104.00 |
| 2026-10-28 | Oppenheimer | -- | Buy | 135.00 |
| 2026-10-28 | J.P. Morgan | -- | Sell | 90.00 |
| 2026-10-27 | Goldman Sachs | -- | Buy | 138.00 |
| 2026-10-27 | RBC Capital | -- | Buy | 125.00 |
| 2026-10-19 | Stifel | -- | Buy | 141.00 |
| 2026-10-19 | J.P. Morgan | -- | Hold | 118.00 |
| 2026-10-16 | Citi | -- | Buy | 148.00 |
| 2026-10-15 | Mizuho Securities | -- | Hold | 110.00 |
| 2026-10-14 | Oppenheimer | -- | Buy | 150.00 |
| 2026-10-13 | Citi | -- | Buy | 148.00 |
| 2026-10-13 | Barclays | -- | Buy | 139.00 |
| 2026-10-13 | RBC Capital | -- | Buy | 135.00 |
| 2026-10-12 | Citi | -- | Buy | 148.00 |
| 2026-10-05 | UBS | -- | Hold | 112.00 |
| 2026-09-15 | Wolfe Research | -- | Hold | -- |
| 2026-08-24 | Jefferies | -- | Buy | 150.00 |
| 2026-08-13 | UBS | -- | Hold | 138.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-11-04 | Argus Research | Buy → Hold | -- |
| 2026-10-28 | Barclays | Buy → Hold | 104.00 |
| 2026-10-28 | J.P. Morgan | Hold → Sell | 90.00 |
| 2026-06-25 | Jefferies | Hold → Buy | 140.00 |
| 2026-04-20 | UBS | Buy → Hold | 132.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-27 | -- | ±5.90% | -14.21% (beat) |
| 2026/Q2 | 2026-07-28 | -- | ±6.65% | +4.00% (in line) |
| 2026/Q1 | 2026-04-28 | -- | ±5.51% | -4.53% (in line) |
| 2025/Q4 | 2026-02-10 | -- | ±4.70% | -8.04% (beat) |
| 2025/Q3 | 2025-10-28 | -- | ±5.08% | +0.74% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±5.64% | +10.74% (beat) |
| 2025/Q1 | 2025-04-29 | -- | ±6.50% | +2.33% (in line) |
| 2024/Q4 | 2025-02-04 | -- | ±6.89% | +5.24% (in line) |
| 2024/Q3 | 2024-10-31 | -- | ±7.88% | -6.48% (in line) |
| 2024/Q2 | 2024-07-30 | -- | ±6.51% | -5.69% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±6.30% | +3.84% (in line) |
| 2023/Q4 | 2024-02-06 | -- | ±5.68% | +4.80% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:33:55 · For reference only, not investment advice and not tailored to your situation.
Xylem discussion 0 comments